IL18 and breast cancer: In this study, it was found that pre-treatment with LGR-1 could effectively alleviate the increase of NLRP3, ASC, the cleavages of Caspase-1 and GSDMD, IL-1β, and IL-18 caused by BC, while treatment with LGR-1 alone did not have any effect.